# HEROIC (Heparin Requirement in Counterpulsation)

> **NCT00445211** · PHASE2 · TERMINATED · sponsor: **Corewell Health East** · enrollment: 46 (actual)

## Conditions studied

- Cardiogenic Shock

## Interventions

- **DRUG:** Heparin
- **OTHER:** Without Heparin

## Key facts

- **NCT ID:** NCT00445211
- **Lead sponsor:** Corewell Health East
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-01
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** lack of enrollment
- **Last updated:** 2017-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00445211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00445211, "HEROIC (Heparin Requirement in Counterpulsation)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00445211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*